What is the role of estrogen receptor binding site variation in the pathophysiology of bipolar affective disorder (manic-depressive illness) in females?

Updated: May 30, 2019
  • Author: Stephen Soreff, MD; Chief Editor: Glen L Xiong, MD  more...
  • Print

Although most of the present research does not stratify by sex, a recent study looked at association between estrogen receptor binding site variation with bipolar disorder in females. In particular, the association is with the transglutaminase 2 (TGM2) gene, which is known to be under estrogenic control. [31] This is further evidence of the heterogeneity of bipolar disorder and also presents evidence to explain the differences in the epidemiology of bipolar disorder between women and men.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!